Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery.
Claudia Elizabeth ImperialiJuan Carlos Lopez DelgadoMacarena Dastis-AriasLourdes Sanchez-NavarroPublished in: Advances in laboratory medicine (2020)
These findings suggest that postoperative ΔIPF and Δhs-TnT may be useful biomarkers for the identification of patients at risk of MACE development.